Advances in Immunotherapy Clinical Trials: Putting Patients First

In this latest CRI cancer immunotherapy webinar for patients and caregivers, Dr. Joshua Brody — a CRI-funded scientist at Mt. Sinai Hospital in New York City — and a breast cancer patient, Stephanie Gangi, will discuss the value clinical trials can offer patients and how the patient voice has become increasingly important when planning clinical studies. Stephanie has been navigating breast cancer for more than twenty years, and it is a new vaccine approach based on Dr. Brody’s CRI-funded work that is keeping her healthy and hopeful for herself and other cancer patients now benefiting from advances in cancer immunotherapy.

Funding for our webinar series has been generously provided by Bristol Myers Squibb, with additional funding provided by Alkermes, BioCanRx, and Lilly Oncology.